- 2024-08-20 01:59抑制剂Islatravir|Islatravir|865363-93-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:59抑制剂Islatravir|Islatravir|865363-93-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂Islatravir|Islatravir|865363-93-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:59抑制剂Iridin|Iridin|491-74-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:59抑制剂Iriflophenone|Iriflophenone|52591-10-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:59抑制剂Iriflophenone|Iriflophenone|52591-10-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂Iriflophenone|Iriflophenone|52591-10-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:59抑制剂IRAK-4 protein kinase inhibitor 2|IRAK-4 protein kinase inhibitor 2|301675-24-1|Adamas life|≥98%（
- 2024-08-20 01:59抑制剂Iridin|Iridin|491-74-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:59抑制剂Iridin|Iridin|491-74-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂IQ-3|IQ-3|312538-03-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:59抑制剂IRAK-4 protein kinase inhibitor 2|IRAK-4 protein kinase inhibitor 2|301675-24-1|Adamas life|≥98%（
- 2024-08-20 01:59抑制剂IRAK-4 protein kinase inhibitor 2|IRAK-4 protein kinase inhibitor 2|301675-24-1|Adamas life|≥98%（
- 2024-08-20 01:59抑制剂IQ 1|IQ 1|331001-62-8|Adamas life|≥97%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂IQ-3|IQ-3|312538-03-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:59抑制剂IQ-3|IQ-3|312538-03-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂IPA-3|IPA-3|42521-82-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:59抑制剂IPN60090|IPN60090|1853164-83-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:59抑制剂IPN60090|IPN60090|1853164-83-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:59抑制剂IPN60090|IPN60090|1853164-83-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
